A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 98,246 shares of NUVB stock, worth $263,299. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98,246
Previous 73,215 34.19%
Holding current value
$263,299
Previous $213,000 5.63%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.3 - $3.83 $57,571 - $95,868
25,031 Added 34.19%
98,246 $225,000
Q2 2024

Aug 14, 2024

BUY
$2.58 - $3.69 $188,894 - $270,163
73,215 New
73,215 $213,000

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $582M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.